---
title: "Sicagen India Ltd (533014) — Share Price, Financials & Analysis"
symbol: "533014"
company: "Sicagen India Ltd"
canonical: "https://tapetide.com/stocks/533014"
isin: "INE176J01011"
nse_symbol: "SICAGEN"
bse_code: "533014"
sector: "Commercial Services"
industry: "Trading & Distributors"
market_cap_cr: 214.32
generated_at: "2026-09-13T19:02:25.343Z"
---

# Sicagen India Ltd (533014)

Canonical page: https://tapetide.com/stocks/533014

## Company

- **NSE Symbol:** SICAGEN
- **BSE Code:** 533014
- **ISIN:** INE176J01011
- **Sector:** Commercial Services
- **Industry:** Trading & Distributors
- **Macro Sector:** Services
- **Stock Type:** EQUITY
- **Listed Since:** 2008-08-21
- **CEO:** Mr. Nandakumar Varma
- **Employees:** 288
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** sicagen.com

## About

Incorporated in 2004, Sicagen India is in the business of trading Building materials, Sales & Servicing Power and controls systems, manufacturing of MS barrels and water treatment chemicals[1]

## Latest Price

- **Price:** ₹53.53
- **Change:** -1.71 (-3.1%)
- **Open:** ₹55.89
- **Day High:** ₹55.89
- **Day Low:** ₹53.11
- **Previous Close:** ₹55.24
- **Volume:** 26131
- **As Of:** 2026-09-11T09:59:09+00:00

## Key Fundamentals

Observed at 2026-09-11T04:45:46.326968Z.

- **Market Cap:** ₹214.32 Cr
- **Classification:** Microcap
- **P/E (reported):** 10.7
- **P/E (TTM):** 14.39
- **EPS (TTM):** ₹3.72
- **Book Value:** ₹125.1
- **Price to Book:** 0.44
- **Dividend Yield:** 1.81%
- **ROE:** 3.65%
- **ROCE:** 7.38%
- **Debt to Equity:** 0.15
- **Revenue (yearly):** ₹983.3 Cr
- **Net Income:** ₹18.1 Cr
- **EBITDA:** ₹49.1 Cr
- **52-Week High:** ₹74.06
- **52-Week Low:** ₹46.55
- **RSI (14):** 47.21

## Tapetide Score

- **Score:** 57 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 77.8 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 57.45 | 9% |
| growth | 48.31 | 9% |
| momentum | 77.42 | 12% |
| ownership | 50 | 24% |
| quality | 53.78 | 22% |
| valuation | 66.94 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.50 times its book value
- Company has been maintaining a healthy dividend payout of 28.2%

### Weaknesses

- The company has delivered a poor sales growth of 8.39% over past five years.
- Company has a low return on equity of 2.68% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 32.04% | 79.59% | — |
| ebitda margin growth | 0.7% | 3.1% | 16.86% | 37.85% |
| net income growth | 53.33% | 5.85% | 15% | 17% |
| revenue growth | 2.49% | 9.27% | 6% | 8% |
| roce | 12.93% | 5.28% | 44.14% | 5.74% |
| roe | 55.38% | 3.11% | 3.16% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 115.84 | 131.46 | 116.31 | 152.55 | 127.32 | 122.73 | 136.09 | 121.57 | 124.68 | 134.33 | 139.69 | 132.93 |
| Expenses | 112.99 | 128.12 | 112.22 | 145.64 | 122.62 | 118.77 | 129.94 | 115.35 | 120.53 | 128.58 | 134.87 | 124.32 |
| Operating Profit | 2.85 | 3.34 | 4.09 | 6.91 | 4.7 | 3.96 | 6.15 | 6.22 | 4.15 | 5.75 | 4.82 | 8.61 |
| OPM % | 2.46 | 2.54 | 3.52 | 4.53 | 3.69 | 3.23 | 4.52 | 5.12 | 3.33 | 4.28 | 3.45 | 6.48 |
| Other Income | 1.33 | 2.2 | 1.29 | 1.38 | 3.15 | 3.23 | 1.72 | 1.86 | 1.66 | 2.52 | 1.6 | 1.63 |
| Interest | 1.23 | 1.38 | 1.44 | 1.4 | 1.54 | 1.36 | 1.51 | 1.61 | 1.41 | 1.46 | 1.43 | 1.53 |
| Depreciation | 1.21 | 1.29 | 1.33 | 1.35 | 1.35 | 1.34 | 1.33 | 1.38 | 1.33 | 1.29 | 1.29 | 1.24 |
| Profit before tax | 1.74 | 2.87 | 2.61 | 5.54 | 4.96 | 4.49 | 5.03 | 5.09 | 3.07 | 5.52 | 3.7 | 7.47 |
| Tax % | 40.8 | 31.36 | 16.48 | 25.45 | 30.85 | 27.17 | 26.44 | 27.9 | 29.64 | 28.8 | 14.86 | 26.64 |
| Net Profit | 1.03 | 1.97 | 2.18 | 4.13 | 3.43 | 3.27 | 3.7 | 3.67 | 2.16 | 3.93 | 3.15 | 5.48 |
| EPS in Rs | 0.26 | 0.5 | 0.55 | 1.04 | 0.87 | 0.83 | 0.94 | 0.93 | 0.55 | 0.99 | 0.8 | 1.38 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 566 | 538 | 434 | 348 | 443 | 439 | 477 | 539 | 520 | 532 |
| Expenses | 563 | 532 | 426 | 336 | 426 | 424 | 460 | 517 | 499 | 508 |
| Operating Profit | 4 | 6 | 8 | 12 | 17 | 15 | 17 | 22 | 21 | 23 |
| OPM % | 0.7 | 1.1 | 1.9 | 3.4 | 3.8 | 3.4 | 3.6 | 4 | 4.1 | 4.4 |
| Other Income | 12 | 8 | 8 | 5 | -2 | 16 | 6 | 9 | 7 | 7 |
| Interest | 7 | 7 | 6 | 4 | 4 | 4 | 5 | 6 | 6 | 6 |
| Depreciation | 2 | 2 | 5 | 5 | 6 | 6 | 5 | 5 | 5 | 5 |
| Profit before tax | 7 | 5 | 5 | 8 | 5 | 20 | 12 | 20 | 17 | 20 |
| Tax % | 9 | 57 | 59 | 30 | 79 | 14 | 27 | 27 | 26 | — |
| Net Profit | 6 | 2 | 2 | 6 | 1 | 17 | 9 | 15 | 13 | 15 |
| EPS in Rs | 1.62 | 0.55 | 0.54 | 1.48 | 0.26 | 4.33 | 2.24 | 3.67 | 3.26 | 3.72 |
| Dividend Payout % | 37 | 72 | 93 | 41 | 98 | 14 | 27 | 27 | 31 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 |
| Reserves | 343 | 346 | 341 | 336 | 350 | 367 | 375 | 384 | 400 | 381 |
| Borrowings | 66 | 53 | 65 | 38 | 35 | 37 | 53 | 50 | 65 | 64 |
| Other Liabilities | 57 | 70 | 59 | 35 | 21 | 29 | 19 | 27 | 27 | 37 |
| Total Liabilities | 505 | 509 | 505 | 448 | 445 | 472 | 486 | 500 | 531 | 522 |
| Fixed Assets | 80 | 82 | 36 | 44 | 43 | 40 | 39 | 40 | 41 | 41 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| Investments | 160 | 146 | 146 | 143 | 154 | 170 | 170 | 175 | 180 | 180 |
| Other Assets | 264 | 281 | 323 | 261 | 248 | 262 | 278 | 284 | 311 | 300 |
| Total Assets | 505 | 509 | 505 | 448 | 445 | 472 | 486 | 500 | 531 | 522 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -12 | -11 | 6 | -37 | 25 | 1 | 11 | 28 | 38 | 25 |
| Cash from Investing Activity | 22 | 20 | 0 | 40 | -17 | 6 | -3 | -11 | -13 | -5 |
| Cash from Financing Activity | -9 | -9 | -8 | -11 | -7 | -9 | -8 | -16 | -11 | -13 |
| Net Cash Flow | 2 | 0 | -1 | -8 | 1 | -2 | 0 | 0 | 15 | 7 |
| Free Cash Flow | -15 | -14 | 48 | -41 | 23 | 4 | 8 | 26 | 40 | 21 |
| CFO/OP | -220 | -266 | 201 | -435 | 231 | 23 | 87 | 179 | 159 | 136 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 75 | 85 | 84 | 88 | 102 | 79 | 66 | 63 | 67 | 72 |
| Inventory Days | 41 | 38 | 39 | 46 | 46 | 35 | 62 | 55 | 46 | 50 |
| Days Payable | 32 | 42 | 38 | 23 | 11 | 17 | 9 | 9 | 11 | 18 |
| Cash Conversion Cycle | 84 | 81 | 85 | 110 | 137 | 97 | 118 | 110 | 102 | 105 |
| Working Capital Days | 41 | 49 | 48 | 97 | 103 | 100 | 103 | 94 | 80 | 83 |
| ROCE % | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 5 | 5 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 55.46% | 55.46% | 55.46% | 55.46% | 60.39% | 60.39% | 60.39% | 60.39% | 61.13% | 61.13% | 61.13% | 61.13% |
| FIIs | 7.34% | 7.34% | 7.34% | 7.34% | 2.42% | 2.42% | 2.42% | 2.85% | 2.42% | 2.47% | 2.47% | 2.47% |
| DIIs | 0.03% | 0.03% | 0.6% | 0.6% | 0.6% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% | 0.58% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 28.34% | 28.84% | 28.69% | 28.76% | 28.65% | 28.62% | 28.37% | 27.89% | 27.56% | 27.6% | 27.54% | 27.38% |
| Others | 8.83% | 8.33% | 7.9% | 7.83% | 7.94% | 7.99% | 8.24% | 8.28% | 8.32% | 8.22% | 8.28% | 8.44% |
| No. of Shareholders | 25160 | 25114 | 24726 | 24309 | 24855 | 24453 | 23934 | 23668 | 23326 | 23057 | 22183 | 22070 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 5 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 56.59 | Sell |
| EMA (10) | 56.1 | Sell |
| SMA (20) | 55.85 | Sell |
| EMA (20) | 56.16 | Sell |
| SMA (50) | 54.76 | Sell |
| EMA (50) | 55.42 | Sell |
| SMA (100) | 54.44 | Sell |
| EMA (100) | 54.95 | Sell |
| SMA (200) | 54.44 | Sell |
| EMA (200) | 56.14 | Sell |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 42.83 | Neutral |
| MACD (12,26,9) | 0.13 | Sell |
| Stochastic (14,3,3) | 30.29 | Neutral |
| ADX (14) | 15.76 | Neutral |
| Williams %R (14) | -92.32 | Buy |
| ATR (14) | 2.73 | High Volatility |
| ROC (12) | -2.6 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 39.24 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=193146ae-4c74-42e0-8e8f-f12f04ef002e.pdf) |
| 2026-08-27 | [Announcement Under Regulation 30 (LODR) - Letters To Shareholders Under Reg. 36(1)(B) Of SEBI (LODR) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e955dac8-5713-4cd7-9389-9a3994542fa3.pdf) |
| 2026-08-26 | [Announcement Under Regulation 30 (LODR) - Letters Sent To Physical Shareholders To Update Their PAN/KYC/Nomination Details](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7444cdcc-abdb-4eff-8a23-66839c791924.pdf) |
| 2026-08-25 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b4d504ee-3556-405e-8ee8-4f6d1fb45a49.pdf) |
| 2026-08-25 | [22Nd Annual General Meeting On 17.09.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49429c20-c872-4a98-befb-aaab0a42bb43.pdf) |
| 2026-08-20 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=057dcbf9-9c0f-442e-a5d0-27bc3685e6ae.pdf) |
| 2026-08-10 | [Board Meeting Outcome for Outcome Of The Board Meeting Dated 10.08.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89a449b3-50a6-4e99-9ce6-549cbd928fe5.pdf) |
| 2026-08-10 | [Intimation Regarding 22Nd Annual General Meeting Book Closure And Record Date](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03a85662-e638-4d3e-9ba0-d7756bfd7882.pdf) |
| 2026-08-03 | [Board Meeting Intimation for For Consideration And Approval Of The Un-Audited Financial Results For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0c8b86d-a1d2-4306-a82b-878a2f1b217a.pdf) |
| 2026-07-10 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3352174-9178-4260-91e9-e8f5b9a9a79d.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-10 | [Unaudited Financial Results For The Quarter Ended 30Th June 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c98ce2b-3d46-4122-b1a0-09db357af5af.pdf) |
| 2026-05-13 | [Audited Financial Results For The Quarter & Year Ended 31.03.2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f1a09e6-798f-47a8-9f55-098a51929442.pdf) |
| 2026-01-30 | [Un-Audited Financial Results For The Quarter & Nine Months Period Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b400ce51-4404-490f-a07a-1d4d0666ffc6.pdf) |
| 2025-10-31 | [Un-Audited Financial Results For The Quarter & Half Year Ended 30Th September 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f9fe288-9be2-434a-b645-19cd71b06abf.pdf) |
| 2025-08-12 | [Unaudited Financial Results For The Quarter Ended 30Th June 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08a482f9-dce5-41b8-96b7-2c53e5e4dc2b.pdf) |
| 2025-05-12 | [Audited Financial Results For The Quarter & Year Ended 31.03.2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f7133bd-5bfb-452a-9430-1c900b1c6867.pdf) |
| 2025-02-07 | [Unaudited Financial Results For The Quarter & Nine Months Ended 31.12.2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df79a88f-439a-4c90-aa18-22aea4f91de2.pdf) |
| 2024-11-05 | [Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended 30Th Sept'' 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea8ad2f0-bc96-4cf8-97e5-7566c96509dc.pdf) |
| 2024-08-07 | [Unaudited Financial Results For The Quarter Ended 30Th June, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cf7ab16-a259-48cd-8e6d-427f23b54d7f.pdf) |
| 2024-05-15 | [Audited Financial Results For The Quarter And Year Ended 31St March, 2024 Together With The Auditors Report Thereon.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6a7ff050-935e-4212-a94d-4d72f4553703.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 March 2026 - Maitreya Hospital Private Limited ("Subsidiary Company") of Maitreya Medicare Limited has formally inaugurated its new Multi-Specialty Hospital in Valsad''. | [Updates 9 March 2026 - Maitreya Hospital Private Limited ("Subsidiary Company") of Maitreya Medicare Limited has formally inaugurated its new Multi-Specialty Hospital in Valsad''.](https://nsearchives.nseindia.com/corporate/MAITREYA_09032026111850_INTIMATION_TO_STOCK_EXCHANGE.pdf) |
| 9 January 2026 - Certificate confirming dematerialisation processing for quarter ended December 31, 2025. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 January 2026 - Certificate confirming dematerialisation processing for quarter ended December 31, 2025.](https://nsearchives.nseindia.com/corporate/MAITREYA_09012026130753_REG74_5_.pdf) |
| 9 Jan - Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31st December, 2025. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Jan - Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31st December, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9c38f3cc-036b-4b8d-bba0-99e0deaa0265.pdf) |
| 7 May - Board meeting on 13 May 2026 to approve FY26 audited results and consider dividend. | [Board Meeting Intimation for Approval Of The Audited Financial Results And Recommendation Of Dividend, If Any. 7 May - Board meeting on 13 May 2026 to approve FY26 audited results and consider dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/25db5c20-5626-4b1d-9c11-584ace960d13.pdf) |
| 5 December 2025 - 05-Dec-2025: Acquired property in Valsad, Gujarat to set up multi-specialty hospital; operated by wholly-owned subsidiary. | [Agreements 5 December 2025 - 05-Dec-2025: Acquired property in Valsad, Gujarat to set up multi-specialty hospital; operated by wholly-owned subsidiary.](https://nsearchives.nseindia.com/corporate/MAITREYA_05122025171045_INTIMATION.pdf) |
| 30 Jan - Board approved unaudited Q3 (31 Dec 2025) results: Consol revenue Rs26,427 lakh; nine-month Rs69,557 lakh; Q3 PAT Rs493 lakh. | [Board Meeting Outcome for Outcome Of The Board Meeting Dated 30Th January, 2026 30 Jan - Board approved unaudited Q3 (31 Dec 2025) results: Consol revenue Rs26,427 lakh; nine-month Rs69,557 lakh; Q3 PAT Rs493 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/655b8de2-20b1-4cfd-9164-09fb84e202f6.pdf) |
| 29 Apr - Newspaper advertisement dated 28.04.2026 - Notice to Shareholders for re-launching the second 100 days ''Saksham Niveshak'' campaign initiated by IEPF. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Newspaper advertisement dated 28.04.2026 - Notice to Shareholders for re-launching the second 100 days ''Saksham Niveshak'' campaign initiated by IEPF.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f1fa5843-77ac-40db-a5b5-f2609f33a035.pdf) |
| 29 Apr - Newspaper advertisement dated 28.04.2026 - Notice to Shareholders for re-launching the second 100 days ''Saksham Niveshak'' campaign initiated by IEPF. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Newspaper advertisement dated 28.04.2026 - Notice to Shareholders for re-launching the second 100 days ''Saksham Niveshak'' campaign initiated by IEPF.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/f1fa5843-77ac-40db-a5b5-f2609f33a035.pdf) |
| 28 Dec 2025 - Trading window closed from 1 Jan 2026 until 48 hours after Q3/9M (31 Dec 2025) results declaration. | [Closure of Trading Window 28 Dec 2025 - Trading window closed from 1 Jan 2026 until 48 hours after Q3/9M (31 Dec 2025) results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e7df1408-b9f1-4a31-8475-aae4feb97bfa.pdf) |
| 27 Mar - Trading window closed from 15 April 2026 until 48 hours after audited results for year ended 31 March 2026. | [Closure of Trading Window 27 Mar - Trading window closed from 15 April 2026 until 48 hours after audited results for year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/08fb7361-036c-4700-a347-e2b7c7f09eca.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2025 | [Concall - Sep 2025](https://nsearchives.nseindia.com/corporate/MAITREYA_08092025154527_MML_INVESTOR_PRESENTATION.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/MAITREYA_11112024183354_TRANSCRIPT.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/MAITREYA_29052024162503_PRESENTATION.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://nsearchives.nseindia.com/corporate/MAITREYA_16022024124355_EARNINGCALLTRANSCRIPT.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_26900_MAITREYA_2024_2025_A_14072025161148.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_25279_MAITREYA_2023_2024_2908202417243.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6686b817-0b71-4bf0-bfb5-c73ea97aa1f9.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2b8a19d2-ab0e-4eea-934d-3813fee848ea.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf07eb7e-822b-43a9-aa1f-a656e439b886.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/533014/76033533014.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/533014/71196533014.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/533014/65001533014.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/533014/5330140319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/533014/5330140318.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:02:25.343Z.